KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Assets Average (2016 - 2025)

Historic Assets Average for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $207.5 billion.

  • Pfizer's Assets Average fell 472.24% to $207.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $207.5 billion, marking a year-over-year decrease of 472.24%. This contributed to the annual value of $216.4 billion for FY2024, which is 6042.4% up from last year.
  • Pfizer's Assets Average amounted to $207.5 billion in Q3 2025, which was down 472.24% from $207.1 billion recorded in Q2 2025.
  • In the past 5 years, Pfizer's Assets Average ranged from a high of $224.0 billion in Q1 2024 and a low of $108.1 billion during Q4 2021
  • Its 5-year average for Assets Average is $184.1 billion, with a median of $207.1 billion in 2025.
  • Its Assets Average has fluctuated over the past 5 years, first tumbled by 625.37% in 2021, then skyrocketed by 8545.66% in 2023.
  • Quarter analysis of 5 years shows Pfizer's Assets Average stood at $113.9 billion in 2021, then rose by 4.62% to $119.2 billion in 2022, then soared by 85.46% to $221.0 billion in 2023, then decreased by 2.07% to $216.4 billion in 2024, then dropped by 4.11% to $207.5 billion in 2025.
  • Its Assets Average stands at $207.5 billion for Q3 2025, versus $207.1 billion for Q2 2025 and $210.7 billion for Q1 2025.